Bezuclastinib structure
|
Common Name | Bezuclastinib | ||
|---|---|---|---|---|
| CAS Number | 1616385-51-3 | Molecular Weight | 331.37 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C19H17N5O | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of BezuclastinibBezuclastinib (CGT9486; PLX 9486) is a potent inhibitor of c-kit and c-kit D816V (0.0001 |
| Name | Bezuclastinib |
|---|
| Description |
Bezuclastinib (CGT9486; PLX 9486) is a potent inhibitor of c-kit and c-kit D816V (0.0001 |
|---|---|
| Related Catalog | |
| Target |
c-Kit:<1 μM (IC50) c-kit D816V:<1 μM (IC50) |
| References |
[2]. WHO Drug Information, Vol. 35, No. 4, 2021. Geneva: World Health Organization; 2022. |
| Molecular Formula | C19H17N5O |
|---|---|
| Molecular Weight | 331.37 |
| InChIKey | NVSHVYGIYPBTEZ-UHFFFAOYSA-N |
| SMILES | Cc1[nH]nc(C(=O)Nc2cnc3[nH]c(-c4ccccc4)cc3c2)c1C |